Literature DB >> 31712316

Lifestyle modifications for treatment of atrial fibrillation.

Melissa E Middeldorp1,2, Jonathan Ariyaratnam1,2, Dennis Lau1,2, Prashanthan Sanders3,2.   

Abstract

The management of atrial fibrillation (AF) has focused on anticoagulation, rhythm control and ventricular rate control. Recently, a fourth pillar of AF management has been incorporated recognising the importance of risk factor management (RFM). There are several risk factors that contribute to the development and progression of AF, these include traditional risk factors such as age, hypertension, heart failure, diabetes and valvular heart disease. However, increasingly it is recognised that obesity, sleep apnoea, hyperlipidaemia, smoking, alcohol, physical inactivity, genetics, aortic stiffness are associated with the development of AF. Importantly, several of these risk factors are modifiable. We have seen the evolution of RFM programmes which have demonstrated promising results. Indeed, the evidence is now so compelling that major clinical guidelines strongly advocate that aggressive treatment of these risk factors as a key component of AF management. Patients with AF who comprehensively managed their risk factors demonstrate greater reduction in symptoms, AF burden, more successful ablations and improved outcomes with greater AF freedom. In this article, we will review the evidence for the association between cardiac risk factors and AF and assess the burgeoning evidence for improved AF outcomes associated with aggressive cardiac RFM. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  atrial fibrillation; hypertension; metabolic syndrome; obesity; smoking cessation

Year:  2019        PMID: 31712316     DOI: 10.1136/heartjnl-2019-315327

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  13 in total

1.  Etiology, Pathology, and Classification of Atrial Fibrillation.

Authors:  Srishti Nayak; Balaji Natarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2020-03-29

2.  Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age.

Authors:  Jose-Luis Clua-Espuny; Eulalia Muria-Subirats; Juan Ballesta-Ors; Blanca Lorman-Carbo; Josep Clua-Queralt; Elena Palà; Iñigo Lechuga-Duran; Delicia Gentille-Lorente; Alejandro Bustamante; Miguel Ángel Muñoz; Joan Montaner
Journal:  Vasc Health Risk Manag       Date:  2020-10-28

3.  NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.

Authors:  Larry Scott; Anke C Fender; Arnela Saljic; Luge Li; Xiaohui Chen; Xiaolei Wang; Dominik Linz; Jilu Lang; Mathias Hohl; Darragh Twomey; Thuy T Pham; Rodrigo Diaz-Lankenau; Mihail G Chelu; Markus Kamler; Mark L Entman; George E Taffet; Prashanthan Sanders; Dobromir Dobrev; Na Li
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

4.  Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study.

Authors:  Hyo-Jeong Ahn; So-Ryoung Lee; Eue-Keun Choi; Kyung-Do Han; Jin-Hyung Jung; Jae-Hyun Lim; Jun-Pil Yun; Soonil Kwon; Seil Oh; Gregory Y H Lip
Journal:  PLoS Med       Date:  2021-06-08       Impact factor: 11.069

5.  Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times.

Authors:  Olívia Moraes Ruberti; Guilherme Defante Telles; Bruno Rodrigues
Journal:  Curr Cardiol Rev       Date:  2021

6.  Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial.

Authors:  Bao Oanh Nguyen; Harry J G M Crijns; Jan G P Tijssen; Bastiaan Geelhoed; Anne H Hobbelt; Martin E W Hemels; W J Myke Mol; Bob Weijs; Marco Alings; Marcelle D Smit; Robert G Tieleman; Raymond Tukkie; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Michiel Rienstra
Journal:  Europace       Date:  2022-07-15       Impact factor: 5.486

7.  Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

Authors:  Ellen K Chang; Dayana Chanson; Jennifer Berano Teh; Aleksi Iukuridze; Kelly Peng; Stephen J Forman; Ryotaro Nakamura; F Lennie Wong; LiYing Cai; Saro H Armenian
Journal:  J Clin Oncol       Date:  2021-01-08       Impact factor: 44.544

8.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17

9.  Sociodemographic, behavioral, and clinical factors associated with low atrial fibrillation knowledge among older adults with atrial fibrillation: The SAGE-AF study.

Authors:  Colleen Sedney; Hawa O Abu; Katherine Trymbulak; Jordy Mehawej; Ziyue Wang; Molly E Waring; Jane Saczynski; David D McManus
Journal:  Patient Educ Couns       Date:  2020-07-15

10.  Sleep apnea in atrial fibrillation - Highly prevalent, highly relevant, but most patients are not somnolent!

Authors:  Kadhim Kadhim; Dennis H Lau; Prashanthan Sanders; Dominik Linz
Journal:  Int J Cardiol Heart Vasc       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.